Invivyd share price logo

Invivyd

NASDAQ: IVVD

$0.76

+0.01

(+1.22%)

as on

Invivyd Stock Performance

as on September 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.73
    $0.79
    downward going graph

    3.35%

    Downside

    4.59%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.53
    $3.07
    downward going graph

    30.13%

    Downside

    306.45%

    Upside

    downward going graph

Invivyd share price movements today

Previous Close
$0.75
Open
$0.76
Volume
4.4M
Market Cap
$219.9M
Day's Low - High
$0.73 - $0.79
52 Week Low - High
$0.53 - $3.07

Invivyd Historical Returns

1 Month Return
-22.23 %
3 Month Return
-23.06 %
1 Year Return
-38.84 %
3 Year Return
-59.66 %
5 Year Return
0 %

Invivyd Stock Fundamentals & Key Indicators

Check Invivyd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$219.9M

EPS (TTM)

-0.3943

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.89

Industry PE ratio

-2.37

PEG Ratio

-0.026191741168084554

EBITDA

-107.3M

Revenue (TTM)

58.4M

Profit Margin

91.35%

Return On Equity TTM

-59.73%

Invivyd Stock Valuation

Track how Invivyd P/E has moved over time to understand its valuation trends.

Invivyd in the last 5 years

  • Overview

  • Trends

Lowest (-8.23x)

December 31, 2025

Today (-8.23x)

December 31, 2025

Industry (-2.37x)

December 31, 2025

Highest (-0.31x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -8.23x

Invivyd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Invivyd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$219.9MNA-1.8991.35%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Invivyd Stock including INR - Dollar returns

The Invivyd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Invivyd investment value today

Current value as on today

₹67,291

Returns

-₹32,709

(-32.71%)

Returns from Invivyd Stock

-₹38,090 (-38.09%)

Dollar Impact

₹5,381 (+5.38%)

Analyst Recommendation on Invivyd Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Invivyd. Average target price of $10

Invivyd Share Price Target

Get share price movements and forecasts by analysts on Invivyd.

What analysts predicted

92.45%UPSIDE

Target Price

$10

Current Price

$0.7553

Analyzed by

3 Analysts

Target

$10.00

Invivyd target price $10, a slight upside of 92.45% compared to current price of $0.7553. According to 3 analysts rating.

Indian Investors' Interest in Invivyd Stock

Search interest for Invivyd Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:28% versus previous 30 day period

Invivyd Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
2
9
13
11
11
13
17
13
14
Gross Profit
-
2
8
13
10
11
12
16
12
13
Operating Income
-46
-49
-62
-19
-16
-15
-11
-12
-43
-45
EBITDA
-42
-46
-60
-16
-15
-14
-10
-10
-40
-45
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
1
0
0
0
0
0
-
Income Before Tax
-43
-47
-60
-18
-16
-14
-10
-11
-41
-44
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-43
-47
-60
-18
-16
-14
-10
-11
-41
-44
Net Profit Margin
0.00%
96.11%
91.33%
94.76%
92.62%
94.19%
91.71%
93.37%
88.76%
91.09%

Invivyd Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
25
53
Gross Profit
-
-
-
-
23
49
Operating Income
-111
-226
-248
-212
-176
-55
EBITDA
-
-219
-225
-205
-166
-50
Interest Expense
-
-
43
-
-
-
Depreciation
43
0
0
2
3
2
Income Before Tax
-111
-226
-241
-198
-169
-52
Income Tax Expense
-
-
-
-
-
-
Net Income
-111
-226
-241
-198
-169
-52
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
93.63%
92.99%

Invivyd Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-43
-47
-60
-18
-16
-14
-10
-11
-41
-44
Operating Cash Flow
-50
-41
-41
-37
-21
-13
-8
-15
-41
-43
Investing Cash Flow
0
-
0
0
0
0
-
-
0
0
Financing Cash Flow
39
0
0
0
0
0
58
157
0
19
Change in Cash
-11
-41
-41
-37
-21
-13
50
141
-42
-24

Invivyd Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-65
-226
-241
-198
-169
-52
Operating Cash Flow
-14
-184
-219
-173
-170
-58
Investing Cash Flow
-
-50
-230
280
0
0
Financing Cash Flow
129
662
0
1
39
215
Change in Cash
114
427
-450
108
-131
157

Mutual Funds that own Invivyd Stock

Check out the Mutual Funds with significant holdings in Invivyd.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.312479%
9763824
MUTUAL FUND SERIES TRUST
3.077769%
9071995
Fidelity Concord Street Trust
0.57459%
1693657
Driehaus Mutual Funds
0.19067%
562019
FINANCIAL INVESTORS TRUST
0.14549%
428847

Global Institutional Holdings in Invivyd

Funds
Holdings
Lee Ainslie
6.44%
Joseph Edelman
6.27%
Peter Kolchinsky
5.81%
Vanguard
4%
iShares
3.25%

Invivyd News & Key Events

  • img

    Today's Timeline - 01 September

    Tue, 04:50 PM

    -

    Invivyd appoints Marc Elia as CEO, consolidating leadership and strategic oversight amid board reshuffle.

    Tue, 04:57 PM

    -

    Invivyd updates on VYD2311 program, expects top-line data by end of Q3 2026.

    Tue, 08:15 PM

    -

    Cantor suggests Invivyd shares should trade higher after CEO appointment and study update.

Insights on Invivyd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 548.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 44.3% return, outperforming this stock by 103.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, IVVD stock has moved down by -21.3%

About Invivyd

Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
OrganisationInvivyd
Headquarters209 Church Street, New Haven, CT, 06510, US
IndustryBiotechnology
CEOMarc William Elia
E-voting on sharesClick here to vote

Key Management of Invivyd

Name

Title

Ms. Jill Andersen J.D.

Chief Legal Officer & Corporate Secretary

Ms. Rachael Gerlach Ph.D.

Senior Vice President of Regulatory Affairs

Dr. Michael J. Mina M.D., Ph.D.

Chief Medical Officer & Chief Epidemiologist

Mr. Marc William Elia

CEO & Chairperson of the Board

Mr. William E. Duke Jr., M.B.A.

CFO and Principal Financial & Accounting Officer

Mr. Timothy Lee

Chief Commercial Officer

Dr. Robert D. Allen Ph.D.

Chief Scientific Officer

Ms. Kristie Coneys Kuhl J.D.

Chief Communications Officer

Ms. Julie Green M.B.A.

Chief Human Resources Officer

Ms. Katie Falzone CPA

Senior Vice President of Finance

FAQs

What is Invivyd share price today?

Invivyd share price today is $0.76 as on at the close of the market. Invivyd share today touched a day high of $0.79 and a low of $0.73.

What is the 52 week high and 52 week low for Invivyd share?

Invivyd share touched a 52 week high of $3.07 on and a 52 week low of $0.53 on . Invivyd stock price today i.e. is closed at $0.76,which is 75.40% down from its 52 week high and 43.13% up from its 52 week low.

What is Invivyd's market capitalisation today?

Invivyd market capitalisation is $0.00T as on .

How to invest in Invivyd Stock (IVVD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Invivyd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Invivyd Shares that will get you 1.9860 shares as per Invivyd share price of $0.76 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Invivyd Stock (IVVD) from India?

Indian investors can start investing in Invivyd (IVVD) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Invivyd stock (as per the Rupee-Dollar exchange rate as on ). Based on Invivyd share’s latest price of $0.76 as on September 19, 2026 at 8:46 am IST, you will get 13.2398 shares of Invivyd. Learn more about fractional shares .